IMM-H007 nacipran is a potent inhibitor of

is a potent inhibitor of Rho-associated kinase (ROCK) (Ki = 150 nM)

10-pentaoxo-1

IHC analysis with anti-CD31 antibody shows that lenvatinib at 100 mg/kg decreases microvessel density more than anti-VEGF antibody and imatinib treatment

CBB1007 protect cochlear spiral ganglion neurons against cisplatin-induced damage

2-thiazole-1

IMM-H007 nacipran is a potent inhibitor ofIMM H007, an adenosine derivative, is an activator of AMP Activated Protein Kinase (AMPK). IMM H007 is a potential drug for treating cardiac dysfunction. IMM H007 negatively regulates endothelium inflammation through inactivating NF B and JNK AP1 signaling. IMM H007 inhibits ABCA1 (ATP binding cassette subfamily a member 1) degradation and facilitates its cell surface localization in macrophages, thereby promotes cholesterol efflux. Product